Company news

Novacyt SAS news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Information mensuelle sur le contrat de liquidité et sur le nombre total de droits de vote

September 30, 2026

Résultats intermédiaires pour 2026

September 29, 2026

REG - Novacyt S.A. - Liquidity Agreement Monthly Update and TVR

July 1, 2026

REG - Novacyt S.A. - Result of AGM

June 30, 2026

REG - Novacyt S.A. - Publication of Annual Report

June 11, 2026

ALNOV: Revenue up, EBITDA loss narrowed, and cash supports growth and acquisitions

April 30, 2026

ALNOV: Acquisition delivers immediate profitability, expanded portfolio, and direct market access

April 8, 2026

Novacyt agrees to acquire Southern Cross Diagnostics

February 23, 2026

REG - Novacyt S.A. - NIPT Tender Award

January 27, 2026

ALNOV: Revenue up 4% to £20.0m in 2025, with strong cash and growth in Instrumentation and APAC

January 21, 2026

Novacyt SA Expects Slight Increase In H2 2025 Revenues

October 22, 2025

ALNOV: EBITDA loss narrowed, cash remains strong, and reproductive health drives growth

September 30, 2025

REG - Novacyt S.A. - Notice of Results

September 18, 2025

REG - Novacyt S.A. - Appointment of Joint Corporate Broker

September 15, 2025

REG - Novacyt S.A. - Resolution re. Lab 21 HSE Prosecution

September 12, 2025

REG - Novacyt S.A. - Liquidity Agreement Monthly Update & TVR

August 1, 2025

Novacyt SA Expects H1 2025 Revenue To Be About £9.8 Mln

July 29, 2025

ALNOV: Liquidity contract activity increased share holdings to 104,002 and set a €5.00 buyback cap

July 28, 2025

REG - Novacyt S.A. - Launch of LightBench® Discover

July 15, 2025

Annual Report and Accounts for the year ended 2024

June 16, 2025

REG - Novacyt S.A. - Liquidity Agreement and Total Voting Rights

June 2, 2025

REG - Novacyt S.A. - AGM Voting

May 28, 2025

REG - Novacyt S.A. - Notice of AGM

May 12, 2025

2024 Full Year Results Presentation (EN)

May 1, 2025

ALNOV: GBP 8 million in savings and 26% growth in reproductive healthcare drive strong outlook

April 30, 2025

IVDR accreditation for Yourgene® QST*R Base assay

February 20, 2025

ALNOV: FY 2024 revenue up 85% to £19.6m, with strong Reproductive Health and cost efficiencies

January 30, 2025

Further expansion of cost reduction programme

November 14, 2024

Directorate Change

October 31, 2024

ALNOV: Revenue up, DHSC dispute resolved, and cost savings position Novacyt for future growth

September 26, 2024

Successful VAT reclaim of £12.2 million

August 22, 2024

Calls

The 5 newest of 7 calls. Every call is listed under its year.

Decks

The 5 newest of 13 decks. Every deck is listed under its year.